Source / episode info
- **Episode:**440
- **Title:**Divine Intervention Episode 440: High Dose Dexamethasone (New USMLE Perspective)
- **Published:**2023-02-03
- Source:Episode page
One-liner
This episode provides a critical update on Cushing's syndrome workup, emphasizing that while classic testing differentiates pituitary adenoma from ectopic sources, adrenal adenomas present a unique diagnostic challenge because their low baseline ACTH prevents cortisol suppression with any dose of dexamethasone.
High-yield summary
- Initial Screening: The diagnosis requires measuring 24-hour urinary cortisol or late-night salivary cortisol to confirm hypercortisolism.
- ACTH Status is Key: Measure baseline ACTH first to differentiate between ACTH-dependent (high ACTH) and ACTH-independent (low ACTH) Cushing's syndrome.
- Pituitary vs Ectopic: In ACTH-dependent cases, high-dose dexamethasone suppression test (HDDST) typically suppresses cortisol in Cushing's disease (pituitary adenoma), but fails to suppress it when the source is ectopic (e.g., Small Cell Lung Cancer).
- Adrenal Adenoma Trap: If the hypercortisolism is ACTH-independent due to an adrenal adenoma, the baseline ACTH will be suppressed, meaning neither low nor high-dose dexamethasone can induce cortisol suppression.
- Clinical Correlation: High ACTH levels (ACTH-dependent) lead to skin hyperpigmentation because ACTH shares a precursor molecule with Melanocyte Stimulating Hormone (MSH).
Learning objectives
- To perform the appropriate screening tests for hypercortisolism (e.g., 24h urinary free cortisol, late-night salivary cortisol).
- To differentiate between Cushing's disease (pituitary adenoma), ectopic ACTH syndrome, and adrenal adenoma based on baseline ACTH levels and suppression test results.
- To understand the molecular basis of hyperpigmentation in ACTH-dependent Cushing's syndrome via POMC/MSH.
- To recognize that an autonomously functioning adrenal tumor will suppress pituitary ACTH, rendering dexamethasone suppression tests non-diagnostic.
- To interpret the differential response to high vs. low doses of dexamethasone across various sources of excess ACTH.
Board exam buzzwords